Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR2 | P41597 | 7/20 | 0.53 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.53 |
| ▸ | CCR5 | P51681 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.42 |
| ▸ | MC4R | P32245 | 4/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | DPP4 | P27487 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1777769 | 0.85 | CCR2 (0.70) | CCR2KCNH2CCR5MEN1HTT | |
| SCHEMBL12603432 | 0.85 | CCR2 (0.70) | CCR2KCNH2CCR5MEN1HTT | |
| SCHEMBL1779272 | 0.85 | CCR2 (0.51) | CCR2KCNH2CCR5MEN1HTT | |
| SCHEMBL1777766 | 0.85 | CCR2 (0.70) | CCR2KCNH2CCR5MEN1HTT | |
| SCHEMBL1778194 | 0.83 | CCR2 (0.68) | CCR2KCNH2CCR5MEN1HTT | |
| SCHEMBL28776156 | 0.83 | CCR2 (0.59) | CCR2KCNH2CCR5MEN1HTT | |
| SCHEMBL1779318 | 0.83 | CCR2 (0.59) | CCR2KCNH2CCR5MEN1HTT | |
| SCHEMBL27762260 | 0.81 | CCR2 (0.58) | CCR2KCNH2CCR5MAPTSMN1; SMN2 | |
| SCHEMBL1777748 | 0.81 | CCR2 (0.58) | CCR2KCNH2CCR5MAPTSMN1; SMN2 | |
| SCHEMBL1779098 | 0.78 | POLB (0.56) | CCR2KCNH2CCR5MEN1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1966187-A1 | PIPERAZINE COMPOUNDS USEFUL AS ANTAGONISTS OF C-C CHEMOKINES (CCR2B AND CCR5) FOR THE TREATMENT OF INFLAMMATORY DISEASES | AstraZeneca AB (SE) | 2008-09-10 | — | — | EP | disclosed |
| WO-2007071952-A1 | PIPERAZINE COMPOUNDS USEFUL AS ANTAGONISTS OF C-C CHEMOKINES (CCR2B AND CCR5) FOR THE TREATMENT OF INFLAMMATORY DISEASES | ASTRAZENECA AB (SE) | 2007-06-28 | — | — | WO | disclosed |